Columbia University Material Transfer Agreement

The Confidentiality Agreement (CA) is also known as a Confidentiality Agreement (NDA) or Confidential Disclosure Agreement (CDA). The AUTHORITIES protect intellectual property rights in conversations with external parties and facilitate the open exchange of proprietary information. Columbia Technology Ventures is the technology transfer office of Columbia University in New York City. Our main goal is to facilitate the transfer of inventions from academic research to external organizations for the benefit of society at local, national and global levels. Read our vision here. Hear from Orin Herskowitz, Executive Director of Columbia Technology Ventures (CTV), who provides insight into the opportunities and challenges of academic technology transfer both at Columbia University and nationally at our peer institutions. The Office of Sponsored Program Administration (OSPA) is responsible for negotiating and entering into these agreements. Only authorized university administrators can execute these agreements. Each year, CTV manages more than 375 research invention declarations, 100 licensing agreements and 18 new start-ups with more than 750 inventors on the Columbia campus. CTV currently has more than 1,200 patent resources for licensing in research areas such as bio, computer science, equipment, equipment, big data, nanotechnology, materials science, etc. We also work closely with our colleagues at other New York academic institutions on initiatives such as the PowerBridgeNY Clean Energy Proof-of-Concept Center, the NYC Media Lab, and the New York Academic Consortium Health and Biotech Summit. Each year, CTV participates in the founding of more than 20 patented startups and offers advantageous conditions to university startups. Please email techventures@columbia.edu for more information.

The Material Transfer Agreement (MTA) governs the transfer of materials between the supplier and the recipient, such as reagents, plasmids, chemical compounds or certain types of software. Transfers of equipment between the university and a company may take place; university and hospital; University and another university. The following agreements allow for the transfer and exchange of intangible (i.e., confidential) and tangible (i.e., research material) resources. CTV currently has more than 1,200 patent resources for licensing in research areas such as bio, computer science, clean technology, medical devices, nanotechnology and materials science. The income generated then returns to Colombia to be shared with the inventor, the inventor`s laboratory, the department, the school and the university as a whole. Columbia investigators who require a confidentiality or non-disclosure agreement (ADC/NDA) to obtain or disclose confidential information to an external party must direct the request to CTV by completing the online application form above. The Office of Sponsored Program Administration (OSPA) is responsible for negotiating and entering into these agreements. Only authorized university administrators can execute these agreements. A Material Transfer Agreement (MTA) is a contract required to transfer or receive materials from an external entity.

The MTA defines the rights of the supplier and the recipient with respect to the Materials and all derivatives. Biological materials such as reagents, cell lines, plasmids and vectors are the most commonly transferred materials, but ATMs may also be needed for other research materials such as engineering samples, chemical compounds and software. Columbia investigators must file any third-party material transfer agreement with CTV by completing the online application form above. Columbia Technology Ventures is the technology transfer office of Columbia University, based in New York City. Our main goal is to facilitate the transfer of inventions from academic research to external organizations for the benefit of society on a local, national and global basis. Read our mission statement here. Each year, CTV manages more than 375 research invention announcements, 100 licensing agreements, and 18 new start-ups involving more than 750 inventors at Columbia`s sites. CTV currently has over 1200 patents available for licensing in research areas such as bio, computer science, cleantech, devices, big data, nanotechnology, materials science and more.

We also work closely with our colleagues at other New York academic institutions on initiatives such as the PowerBridgeNY Proof-of-Concept Center for Clean Energy, the NYC Media Lab, and the New York Academic Consortium Health and Biotech Summit. Creating a faculty or start-up for graduate students can raise questions about potential conflicts of interest. If conflicts are not properly managed or addressed, they could make the researcher and institution vulnerable to allegations of bias in research and raise regulatory concerns. The Office of Compliance and Research Training is available for consultation. Contact Anderson Smith (aps2180@columbia.edu) to schedule a consultation. When an external party wishes to receive material from a Columbia University researcher or submit material to a Columbia University researcher, CTV reviews all Material Transfer Agreements (MTAs) to ensure that the interests of the university and its researchers are protected. Note: If you are shipping chemical, biological or potentially hazardous materials, please contact MU Environmental Health & Safety: Hazardous Shipping/Transportation. You may need to contact EHS to obtain approval for your shipment in accordance with the 7:040 Business Policy and Procedure.

CTV participates in the creation of more than 20 patent-based startups each year and offers advantageous conditions for university startups. Please email techventures@columbia.edu for more information. To receive an MTA, please email agmts@missouri.edu or call 573-882-0275. CTV actively seeks industry partners and investors and works effectively to enable the following: CTV provides the following services to Columbia faculty, students and staff: Many of Columbia`s inventions have been incorporated into life-saving or life-enhancing products available to consumers around the world, including: Remicade; ReoPro; Tysabri; Zolinza; Synagis; Xalatan; Xalcom; Epogen; Avonex; Herceptin; arrow catheters; MPEG-2; and in Blackberry and Apple products. Columbia Technology Ventures focuses particularly on start-ups. Over the years, CTV has helped found more than 150 companies based on Columbia`s technologies. Of these companies, more than 40 have received venture capital funding, with more than 25 successful acquisitions or IPOs to date. . Once CTV has received the bid, an assigned CTV contracting officer sends an email to the Columbia investigator to confirm receipt of the MTA. The contracting officer will negotiate the terms with the supplier and keep the Columbia investigator informed of the MTA`s progress.

CTV will coordinate the signatures with the Columbia investigator and the provider institution. . Columbia Technology Ventures offers the following services to Columbia researchers:. .